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Abstract The foundation of Germany’s healthcare system
is derived from Germany’s Basic Law (Grundgesetz),
which obliges the state to provide social services to its
citizens (Articles 20, 28 of the Basic Law). Specifically, the
state must ensure sufficient, needs-based ambulatory and
inpatient medical treatment, in qualitative and quantitative
terms, as well as guarantee the provision of medicine. The
federal government may assume this duty itself or delegate
it to state governments and institutions in the form of
service guarantee contracts (§ 72, German Social Insurance
Code, Book V). The following paper provides an overview
of the structural organization, individual components and
funding of the German healthcare system, which, in its
current form, is extremely complex and which even experts
find difficult to grasp.
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Basic principles of healthcare system
Germany’s healthcare system is a contribution-based social
insurance model, whose main features can be traced back to
the beginning of the Middle Ages and even earlier. It is an
important economic area and, with its large workforce of
approximately 4.3 million employees (status in 2007), also
plays a key role in labor market policy. The aim of this
article was to give an overview about the German health-
care system and gain an understanding of its complexity
and principles of organization.
The Germany’s healthcare system is primarily funded by
the public sector, which levies the funding in the form of
social insurance payments, and covers in particular the
costs of state supervision and basic infrastructure (e.g.
administrative bodies and ministries, government institutes
and facilities, public health offices and medical education).
The premiums collected by the public and private health
and nursing insurance companies, on the other hand, are
employed for direct healthcare services, such as the re-
muneration of service providers (e.g. physicians, nurses), the
cost of medicine, therapies and medical aids as well as
equipment. Private households pay deductibles and health-
care expenses such as over-the-counter medicines and
services not covered by health insurance. Healthcare services
are provided by both public (e.g. federal, state, and munic-
ipal government), non-profit organizations (churches and
charities, such as Caritas and the German Red Cross) and
private institutions (companies and individuals with com-
mercial interests), with non-profit and private healthcare
providers providing the bulk of direct services (Table 1).
Basic principles of social rights are used as the
framework for ensuring social security in cases of illness,
and must be followed by both the health insurance
companies and health service providers. The principle of
the welfare state is based on the Federal Republic of
Germany’s Basic Law (Grundgesetz), which specifies that the
state must guarantee all citizens social justice and the equal
participation in society, including appropriate treatment in
case of illness. Individuals with below average earning
power or economic resources must receive the same quality
and quantity of medical care as others. Thus, overall, the
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healthcare system is organized around the principle of
solidarity (Solidarprinzip), which provides that every mem-
ber of a supportive society is entitled to assistance from the
other members of the society in the case of illness. A main
feature of the statutory health insurance scheme is social
reconciliation (Solidarausgleich), which is expressed in two
main ways: firstly, between the healthy and ill, in that all
members – including the healthy – meet the costs of the
necessary treatment and benefits if a member falls ill
regardless of the individual’s economic resources, including
the additional costs of securing the individual’s livelihood,
such as continued wages and sickness benefits; and secondly,
between high and low incomes, in that up to a defined
income threshold, all members of the statutory health
insurance pay an income-dependant percentage of their
earnings. This solidarity model stands in contrast to the
subsidization principle, which provides that an individual’s
expenses are only then assumed by the supportive society if
the individual is demonstrably overextended. Until such a
point, the individual is obliged to contribute to the treatment
costs. In the subsidization model, the healthcare expenses are
met by a sequence of supportive societies from smallest to
largest: the individual, his or her martial or life partner, the
family, the statutory health insurance fund, and finally the
services the individual is entitled to as a citizen (Fig. 1).
Specifically, the state is obligated according to the Basic
Law to provide its citizens with the minimum provisions for a
human life with dignity, including adequate medical care that
meets the needs of the population (principle of meeting need,
Bedarfsdeckungsprinzip), in terms of ambulatory services,
inpatient beds, quantitative and qualitative measures, and the
dispensing of medical products. This is expressed legally as
the service guarantee contract (Sicherstellungsauftrag).
However, the federal government does not have to meet this
obligation directly, but can delegate the service guarantee
contract to state governments and other institutions. In turn,
these contractually obligate healthcare providers and facili-
ties to deliver the services. Consequently, on a legal and
decision-making level, bodies such as the health insurance
companies and associations of statutory health insurance
(SHI) physicians function as indirect, outsourced public
administration authorities with some measure of self-
governance, which take the form of statutory corporations.
By thus relieving the burden on the state, they are in turn
granted substantial say in health policy, and also represent
the interests of their members and implement government
regulation. Representatives of the health insurance compa-
nies and service providers debate and decide key questions
in service provision and remuneration in joint self-
administration. For example, the Federal Joint Committee
(G-BA), on which physicians, dentists, hospitals, health
insurers and patients are represented, has significant influ-
ence on which services are provided by the statutory health
insurers and under which conditions. Its decisions are
binding for both the health insurance companies and SHI
service providers. Furthermore, all parties, including the
insured, the various associations and the funding bodies, are
entitled to legally appeal the decisions reached by the
associations and government authorities as part of the service
guarantee contract.
While, with the exception of military hospitals, the
federal government does not directly fund healthcare
facilities, it does maintain a number of healthcare institutes
and federal agencies, each with its own areas of responsi-
bility. These include the Robert Koch Institute (disease
control and prevention, particularly extremely dangerous or
contagious diseases; federal health reporting), the Paul
Ehrlich Institute (ensuring drug safety; testing, approval
Fig. 1 The subsidization model [1]
1995 2000 2007
Total expenditure 186 474 mln euros 212 335 mln euros 252 751 mln euros
Public sector 10.7% 6.4% 5.2%
SHI insurance 67.3% 69.6% 67.8%
Private health/nursing insurance 7.7% 8.3% 9.3%
Employer contributions 4.2% 4.1% 4.2%
Private households 10.2% 11.6% 13.5%
Table 1 Funding of the German
healthcare system [1]
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and monitoring of vaccinations, sera and blood products),
the German Institute of Medical Documentation and
Information (development of medical classifications and
medical databases), the German Federal Center for Health
Education (development of health education and prevention
strategies), the German Federal Institute for Drugs and
Medical Devices (drug assessment and authorization,
monitoring of legal narcotics trade) and the German Federal
(Social) Insurance Office. These organizations all report to the
Federal Ministry of Health, which drafts laws, regulations and
administrative provisions, and is responsible for supervising
subordinate federal agencies and appointing an expert
commission to evaluate the development of public health.
The highest state authorities are the ministries of social affairs
or health, to which, in turn, other state authorities, such as the
state public health offices, report. The latter ensure compli-
ance with federal and state laws, supervise the institutions
under their responsibility, such as municipal health authorities,
health and social security insurance companies at state level,
the local association of SHI physicians (Kassenärztliche
Vereinigung, KV). The states also directly fund healthcare
facilities, such as the university clinics and state psychiatric
hospitals. Municipalities, as relatively autonomous regional
authorities with a guaranteed right to local self-government,
enforce the legislation governing healthcare professions, the
distribution of foodstuffs and medical products, contagious
disease prevention and control and health education and
counseling, with the public health offices implementing the
various associated measures [1, 5, 7, 9, 10] (Fig. 2).
(Statutory) Health insurance in Germany
Compulsory health insurance was introduced for all
residents in the Federal Republic of Germany on 1st
January 2009. Approximately 90% of citizens living in
Germany are in the statutory health insurance (SHI) system.
A further 9% have private health insurance (PHI), while 2%
have company or trade insurance or are uninsured despite
legal obligation (<1%). Joining the SHI scheme, as opposed
to the private system, is obligatory for individuals, whose
income is below a legally specified amount (income
threshold in 2009: 4050 euros, assessment threshold:
3675 euros), unless they belong to a mandatory SHI-
exempt professional group (see below). Within the SHI
system, the insuree can choose between various health
insurance companies and has also been free to switch
between funds since 1996. At the same time, the statutory
health insurance funds are contractually obliged to accept
any applicant, regardless of health risk profile.
The minimum healthcare that must be provided by all
funds is specified as a list of benefits in Book V of the
German Social Insurance Code (SGB), and includes
maintaining health standards, healing, health education,
counseling on and measures for healthy living conditions.
To meet these requirements, the SHI funds have to provide
the following services: prevention, early detection and
treatment of diseases, medical rehabilitation, contraception,
sterilization, abortion and the provision of maternity and
sick leave allowances. SHI insurees receive the healthcare
services as benefits-in-kind (Sachleistungsprinzip), which
are provided by third parties (e.g. physicians, hospitals,
pharmacists), who subsequently bill the health insurance
company.
SHI expenditure is almost completely covered by
premiums (and to a small extent, also by other funding
such as federal grants), which are calculated according to
earning power, rather than individual health risk profile, as
a percentage (currently 14.9%, beginning with January
2011—15.5%) of income subject to premium levy, with
Fig. 2 The structure of the
German healthcare system [1]
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employers matching the contribution of the employee.
Family members without an income of their own are
usually insured free of charge and certain groups of
insurees (e.g. low-income earners, students, apprentices)
receive a premium reduction. Health premium increases are
not only permitted, but also in fact prescribed by law, if
expenses increase and can no longer be met by the SHI
scheme. Such increases are limited to 1% of income subject
to premium levy, whereby an increase of 8 euros a month is
permitted without prior assessment of the insuree’s income.
The statutory health funds are not permitted to operate on a
for-profit basis and excess contributions must be reim-
bursed to insurees (generally in the form of premium
reductions). Deductibles and supplementary charges (such
as for prescription medicine) are limited in total to 2% (1%
for the chronically ill in ongoing treatment) of the
individual’s gross income to avoid disproportionately
burdening the individual insuree.
Funding of the SHI scheme is managed by means of a
centralized health fund (Gesundheitsfonds) and a morbidity-
based risk adjustment scheme (Morbi-RSA). In this system,
the health insurance companies are obliged to transfer all
premiums, excluding supplementary charges, to the federal
bank. Federal grants for health infrastructure are also paid
into this fund. The health fund is administrated by the
Federal (Social) Insurance Office, which determines how
much of the fund will be allocated to each insurance
company based on specific criteria, which together comprise
the morbidity-based risk adjustment scheme. Features include
a uniform monthly basic flat rate (2009: 185 euros) and
administrative flat rate (2009: 5 euros) for each insuree, as
well as bonuses and deductions based on the individual’s age,
sex and illnesses (a selection of 80 groups of diseases are
included as factors).
As statutory corporations, the health insurance companies
are supervised by the state, without themselves being agencies
of the state. They are self-governing. Every 6 years, the
premium-paying insurees elect an advisory board to the
association of health insurance funds. This board in turn
elects a board of directors, which represents the health
insurance companies in the public sphere [1, 2].
Private health insurance
Private health insurance (PHI) companies are corporations
subject to private law, which operate on a for-profit basis. A
little over than half (2008: 47 of a total of 83 PHI
companies) are members of the Association of Private
Insurers (Verband der privaten Krankenversicherungen e.V.).
Private health insurers not in the association are usually
‘supplementary’ funds (which primarily offer additional
services, but not full health insurance coverage). The
association’s insurance companies can be divided into two
groups: mutual insurance associations (these are self-
governing and profits are paid to the insurees) and
shareholder companies (these are managed on behalf of the
shareholders and profits are paid to the shareholders).
Only employees whose regular income is above the
insurance threshold, civil servants, clergy, private school
teachers, pensioners and the self-employed can choose the
private health insurance system over the SHI scheme. A
voluntary member of the SHI scheme can only switch to the
PHI system if their earnings have been above the
compulsory insurance threshold for three consecutive
calendar years. Whether a private health insurer accepts
the applicant depends primarily on the applicant’s health
risk profile, which is assessed for each potential new
insuree. Unlike the statutory health insurers, private health
insurers do not have a contractual obligation to accept
applicants. They can also demand additional risk premiums
or exclude particular services from the contract (with
limited exceptions). As part of the health risk portfolio
process, the applicant has to release physicians and any
other involved healthcare workers from their non-disclosure
agreements. If the applicant is accepted, the insuree chooses
between various services to create a specially tailored
benefits package. The premium is calculated based on the
individual’s predetermined health risk portfolio, which
includes the applicant’s age on joining, state of health on
application, gender, as well as the type and extent of the
services covered (equivalency principle). If the private
health insuree is an employee, the employer pays 50% of
the premium, in so far as the sum does not exceed the
average SHI premium.
The private health insurer provides the insuree with cash
benefits, in the form of reimbursements for medical
treatment expenses. The level of these reimbursements
depends on the individual insurance contract. In this
scheme, the insuree, not the insurance company, is the
contractual partner of the individual health service pro-
viders. Additionally, unlike the SHI, private insurance
funds do not enter into service provision contracts with
physicians or hospitals (with a few exceptions). The insuree
chooses the service provider and meets the incurred costs,
which are later reimbursed by the insurance company
(based on the individual contract, either in full or in part).
The service provider’s bill usually takes the applicable SHI
fee schedule for the service in question (e.g. the physicians’
fee schedule, GOÄ) as its starting point, but can be 3.5
times that of the fee schedule rate, depending on the type of
service and the time required. If a (costly) hospital stay is
planned, the hospitals are entitled to demand advance
payment. To prevent the insurance premiums from increas-
ing too steeply with age and the associated higher expenses,
the private insurers charge younger members higher
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contribution rate than necessary for their age and condition
of health (aging provision).
Private health insurers are also obliged to offer specified
minimum services, the cost of which may not exceed the
corresponding highest SHI rates. For instance, certain
insurees, depending on the individual’s age and how long
they have been a member, are offered a standard tariff,
which includes the same benefits are that offered by the
SHI scheme. Since 1st January 2009, new insurees also
have a right to a uniformly calculated basic tariff that
corresponds to the SHI benefits catalogue. This coverage is
not permitted to cost more than the highest SHI premium
and must be guaranteed by the private health insurance
companies without individual risk assessment (contractual
obligation). Additionally, private health insurers are in
principle not allowed to terminate contracts that serve to
fulfill the obligation of compulsory insurance. However,
they are entitled to raise an insuree’s premium if the costs
rise (e.g. service and price increases in healthcare, legislature
changes), if authorization is first obtained from a state
insurance office-appointed fiduciary. If in a calendar year an
insuree does not use any medical services, or only to a limited
extent, the private health insurer generally reimburses them
with up to several months of contribution payments [1, 11, 12]
(Table 2).
Ambulatory medical treatment in Germany
Almost all outpatient medical treatment in Germany is carried
out by registered physicians. These are self-employed in
individual or joint practices (joint use of surgery rooms by
various independent physicians with their own patient files
and separate billing), joint surgeries (several physicians in one
surgery, with joint patient files and billing) and medical
treatment centers (physician-led, interdisciplinary centers, in
which at least two doctors with different medical specialties
work, often with other participating health practitioners, such
as pharmacists, physiotherapists, medical and rehabilitation
technology companies). Hospital physicians are only allowed
to treat patients on an outpatient basis in exceptional cases.
Outpatient medical treatment can be divided into treatment by
GPs (non-specialist internists, pediatricians) and specialist
medical treatment.
Importantly, physicians can only bill the statutory health
insurance companies for the treatment of SHI patients
(approx. 90% of the population) if they have been approved as
SHI physicians (approx. 95% of all registered physicians).
Without SHI approval, physicians may only treat private
patients or SHI patients who choose to pay for the treatment
directly. Statutory health insurers only cover the costs of
medical treatment of a SHI insuree by a private physician in
cases of proven emergency. If listed in the association of SHI
physicians’ register of medical practitioners and having
received either specialist training or at least 6 years training
as a GP, a physician can apply for SHI-approval status.
Whether the applicant is approved is decided jointly by
representatives of the association of SHI physicians and the
statutory health insurance companies. The decision depends
primarily on the need for outpatient medical services in the
relevant health-planning district and the SHI physician must
then maintain their practice in this district. Since 1999,
psychotherapists can also apply for the status of SHI-
approved physicians, if they are members of the applicable
association of statutory health insurance physicians and
participate in the SHI fee distribution system (see below).
The SHI physician must be a member of the relevant
association of SHI physicians, and as such, must adhere to
certain guidelines. These include that the SHI physician has
to provide the SHI treatment personally and is not allowed
to be have another physician substitute for them for more
than 3 months annually. The physician provides treatment,
decides whether follow-up visits are necessary, refers
patients to other specialist physicians where necessary,
initiates hospitalization, prescribes drugs and decides
whether home care is required. SHI physicians are subject
to the laws governing the profession, the regulations of the
federal and state associations of SHI physicians, the
Treatment Obligations Ordinance, and are obliged to meet
certain regulations regarding the distance between surgery
and home residence, maintain regular consultation hours,
participate in after-hours emergency rostering, document
the work, report to the health insurers and ensure that the
treatment provided is sufficient, appropriate and cost-
effective and does not exceed the limits of the necessary.
If approved to do so by the association of SHI physicians,
the SHI physician may employ assistant doctors in training
or another physician in the same field of expertise.
1995 2000 2007
Statutory health insurances funds 960 420 253
SHI insurees 71,886 mln 71,252 mln 70,314 mln
Private health insurances funds 54 50 49
PHI insurees 6,994 mln 7,522 mln 8,249 mln
Table 2 Number of statutory
and private health insurance
funds and insurees in
Germany [1]
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Virtually all outpatient medical treatment is financed by
the SHI. Other contributors include the private health
insurers, private households (including quarterly copay-
ments and deductibles), employers and public funding (e.g.
remuneration of medical treatment provided to welfare
recipients). Germany’s remuneration system is extremely
complex and is based on a number of different systems.
The health insurers compensate the SHI-approved treatment
of its members as lump sums per insuree, negotiated with
and paid to the association of SHI physicians. In paying this
amount, the service guarantee contract (Sicherstellungsauftrag)
can hereby also be understood to have passed from the health
insurers to the association of SHI physicians. Remuneration of
the SHI physicians takes the form of a fee distribution system.
The SHI physician submits the SHI-approved services to the
applicable association of SHI physicians on a quarterly basis.
In return, after a multistep auditing process, the association
remunerates the physician as a proportion of the lump-sum
compensation paid by the health insurer. The compensation is
initially paid as a preliminary installment (the physician
receives the remaining proportion once all SHI-services in
the individual health planning district have been settled). A
defined proportion of the lump-sum compensation is assigned
to each SHI physician. If the physician exceeds that amount
by more than 10%, the excess services are only remunerated
by a reduced factor. In addition to the lump-sum compensa-
tion, services that the state believes require special promotion
(e.g. disease prevention, maternity care) are remunerated
separately. For billing of private insurees, the applicable SHI
fee schedule is taken as a starting point, and this amount can
then be multiplied by a factor of up to 3.5, depending on the
type of service and the time required, and are remunerated by
the user directly, who is then reimbursed by the health
insurance company [1, 2, 7, 9–12] (Tables 3 and 4).
Associations of SHI physicians
The associations of SHI physicians (17 in total) assume
state duties as statutory corporations, but at the same time
also represent the interests of the SHI physicians. Each
association elects a representative assembly, whose respon-
sibility it is to define the statutes, appoint representatives
from their body for the joint self-administration commis-
sions of the physicians and health insurers, and to elect a
full-time board of directors every 6 years. This board
represents the association in the public sphere and
concludes contracts and agreements that are binding for
all SHI physicians. The association’s obligations include
ensuring sufficient outpatient treatment (quantitatively and
qualitatively, including outside of regular consulting hours).
To meet this obligation, the association draws up a
consumption plan. A new medical practice is only possible
if the density of medical services within the health-planning
district is less than 110%. If the number of physicians in a
particular specialist area exceeds the set threshold set for
the planning zone by more than 10%, the planning district
is flagged as oversupplied and restrictions on the approval
of new service providers are set. In this case, new
physicians can only practice in the district by joining
existing surgeries or practices, either by taking the practice
over or by forming a joint practice. If a planning district is
undersupplied, the associations of SHI physicians are
obliged to take appropriate counter-measures by motivating
physicians to open surgeries in these areas (e.g. by means
of financial bonuses, low-interest loans and/or guaranteed
minimum turnover volume). The association has a duty to
the health insurers to ensure that the SHI-approved
treatment fulfills the contractual requirements.
Cooperation in the form of joint self-administration with
health insurers is compulsory for the associations. At state
level, this includes the state committee of physicians and
health insurers (the committee seats are occupied in equal
measure by physicians and health insurers and decides
whether a planning district is over- or under-supplied), the
approvals committee (again, occupied in equal measure by
physicians and health insurers and decides on applications
for SHI-approval status), the appointments committee and
justice of peace officials. These self-administration com-
mittees report to the state. An additional responsibility of
the association is representing the economic and profes-
sional interests of the SHI physicians. This includes
negotiating contracts and remuneration packages with the
state health insurance associations. In this way, the
association has significant influence on the general con-
ditions of the medical care provided by SHI physicians.
One of the association’s key duties is negotiating and
distributing the lump sum medical service compensation
discussed above. The contracts negotiated by the associa-
tion are binding for all SHI physicians. The associations
Table 3 Number of SHI physicians [8]
1995 2000 2007 2009
Physicians providing SHI
services
119,939 126,832 134,172 137,416
Number of SHI physicians 17,235 114,491 120,232 121,128
Table 4 GP vs. specialist SHI physicians in Germany in 2009 [8]
Registered SHI physicians Medical treatment Proportion
GPs Specialists GPs Specialists
121,128 57,631 63,497 47.6% 52.4%
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also represent the interests of the SHI physicians in the
public sphere and have input in important health policy
decisions at state level. At federal level, the Federal
Association of SHI physicians (KBV) assume this respon-
sibility. It issues uniform federal guidelines, works together
with the Federal Joint Committee, maintains the federal
physicians’ register and lobbies the federal government on
behalf of SHI physicians. The federal association also has a
representative assembly and a full-time board. Both the
state and federal associations are financed by member
contributions, which are deducted by the associations for
each SHI physician from the lump sum compensation paid
by the health insurers [1, 2, 7, 9, 10].
Medical associations
In contrast to the associations of SHI physicians, medical
associations (17 in total) focus on the regulation of the
professional practice. They specify the rights and duties of
physicians in a professional code of conduct, and define
continuing education requirements for specialist training.
Additionally, the medical associations enforce compliance
with professional duties and form commissions that address
various issues, including a mediation commission, expert
commissions (for medical malpractice) and review boards
(to evaluate research proposals). These associations are also
statutory corporations under state law and all physicians
(not just the SHI physicians) must be members of a medical
association, even after retirement. Medical association
members elect representative assembly delegates, who, in
turn, elect a board of directors. At federal level, the medical
associations are merged in the German Medical Association
(Bundesärztekammer, BÄK). The federal association’s
primary tasks include a coordinating role for the state medical
associations, the organization of networking events and
structures, ensuring the uniformity of professional and
continuing training guidelines, representing the medical
profession in the public sphere and lobbying at policy level
[1, 2, 9, 10] (Fig. 3).
Hospital medical treatment in Germany
The hospital funding law (Krankenhausfinanzierungsgesetz,
KHG) defines hospitals as institutions for the diagnosis,
curing or alleviation of diseases, ailments or physical injury
and the performance of obstetrics by physician or nurses, in
which the patients can be provided with room and board.
Hospitals approved to treat SHI insurees must fulfill
additional requirements. For instance, the hospitals have to
a) be under the continual medical management of physicians,
b) have sufficient diagnostic and therapeutic capabilities to
meet the terms of the hospital provision contract, c) work
according to scientifically recognized methods, d) which can
be applied by around-the-clock medical, nursing, support
and technical staff, e) to diagnose, cure, arrest and alleviate
illness or provide obstetrics, primarily through physician and
nursing care, f) and which can provide patients with room
and board. Rehabilitation centers and similar, specialized
inpatient facilities are not considered hospitals. Hospitals are
divided into general and other hospitals (hospitals with only
psychiatric and/or neurological beds, and purely day or night
clinics, in which patients are treated as partial inpatients).
Depending on the funding body, the hospitals are public
(local district, state, federal government or statutory corpora-
tion hospitals), non-profit (the funding bodies have religious,
humanitarian or social goals) or private (the funding body has
commercial goals, e.g. Belegkrankenhäuser, which are
smaller hospitals, in which physicians can, unlike in other
hospitals, treat patients on both an outpatient and inpatient
basis). Each hospital has physician, nursing and business
administration teams, which are headed by a medical
director, director of nursing, business director, respectively,
Fig. 3 Ambulatory medical
treatment in Germany [1]
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who together comprise the hospital management. Some
hospitals employ a chief executive officer, who carries the
overall responsibility for the hospital. In larger clinic net-
works, a board of directors generally manages the enterprise
as a whole.
Even though some states delegate the service guarantee
contract to municipalities, the responsibility for adequate
hospital care remains that of the state in the final instance.
The states are obliged to assess the need for services within
their district in a process known as hospital planning.
Hospital planning is based, on the one hand, on a needs
assessment of the current and projected requirement for
hospital services, and, on the other hand, on an evaluation of
whether the existing staffing and infrastructure can be
expected to meet the identified need for services. The process
and criteria must comply with the regulations of the hospital
law and the applicable state hospital law. If the existing
provisions do not meet the requirements, additional hospitals
are included in the needs assessment. Hospital planning
comprises two main components: the hospital plan itself
(which specifies all suitable hospitals necessary for providing
adequate and sufficient care) and an investment program. The
state authorities responsible for the hospital planning and
the investment program are the social security or health
ministries. Once a hospital is included in the hospital plan, it is
SHI-approved and obliged to provide treatment to SHI
insurees (in the case of university clinics, registration in the
university directory is considered equivalent). In return for
assuming responsibility for the service guarantee contract, the
SHI-approved hospitals have a right to remuneration from the
health insurance companies for the services provided, as well
as public investment funding from the state government.
The hospital system is funded by two main sources:
health insurance premiums (which cover the hospital’s
ongoing operating costs) and tax funds (which cover
investment expenditure). Small and medium investments,
such as the replacement of furnishings, are covered by
lump-sum grants and each hospital in the hospital plan has
a legal entitlement to such funding. In contrast, hospitals
must apply to the government for funding of larger
investment measures, such as new buildings or renovation.
Hospitals do not have a guaranteed right to large investment
funding. Instead, funding is decided based on the budgetary
situation. The health insurers are contractually obliged to
negotiate a budget and a nursing care allowance with each
hospital in the hospital plan. Each of these hospitals has the
right to a customized budget, negotiated with the health
insurers (individualism principle) and is generally negotiat-
ed as a lump-sum for the following calendar year. Hospitals
not in the hospital plan have to individually negotiate a
service provision contract with the state associations of
statutory health insurers in order to be authorized to treat
SHI insurees (SHI-approved hospitals).
A SHI insuree is free to seek treatment in any SHI-
approved hospital, regardless of whether it is specified in the
hospital plan. Except in emergencies, the patient requires a
hospital referral from a registered SHI physician. In both
cases, the attending hospital physician decides whether an
inpatient stay is necessary. Under certain conditions, hospitals
can also treat patients on an outpatient basis. Only specially
authorized hospital physicians are permitted to carry out such
ambulatory treatment and the authorization is granted by the
approval committee of the applicable association of SHI
physicians (for a limited, renewable term). A prerequisite is
that adequate treatment is only possible if the hospital
physician in question is authorized to provide outpatient
treatment. An exception is the university outpatient centers of
the university hospitals; these have general and unlimited
permission to provide treatment on an outpatient basis.
Outpatient operations and highly specialized services for rare
diseases and illnesses with special illness progression, listed in
the service catalogue according to Book V of the German
Social Insurance Code, are also approved for ambulatory
treatment. Additionally, in medical care centers (Medizinische
Versorgungszentren, MVZ), which are interdisciplinary,
physician-managed institutions, physicians may work on an
employee basis or as self-employed SHI-approved medical
professionals. While hospital physicians usually carry out
the hospital treatment, general practitioners, if SHI-approved
and with special authorization from the association of SHI
physicians, can also treat patients on an inpatient basis—a
provision that is limited to hospitals or hospital capacity also
authorized for this purpose. This inpatient treatment is
remunerated from the overall compensation package for
outpatient medical treatment, while the hospital expenses are
charged to the patient or health insurance company in a
separate billing procedure.
The hospital system has a joint self-administration
structure. Unlike the outpatient treatment system, this self-
administration authority is an association subject to private
law and not a statutory corporation. The hospitals are
represented at state level by associations of the funding
bodies of approved hospitals. In joint self-administration
with the state associations of the SHI and the private health
insurers, they reach framework decisions for the negotiation
of overall budgets and the daily rate for patient care, as well
as for hospital planning. At federal level, the German
Hospital Association (Deutsche Krankenhausgesellschaft,
DKG) works together with the SHI and private health
insurance companies’ umbrella associations, also in joint
self-governance. Their role is declaring joint recommenda-
tions (including for the state-wide average cost of cases, a
value that is agreed on annually and on which the fee
schedule of hospital treatment is based).
A further task of the hospital association is the ongoing
development of the DRG (diagnosis-related groups) patient
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classification system, in which a certain total of patients are
divided into case groups based primarily on medical
criteria. Primary and secondary diagnoses, and the medical
services corresponding to the diagnoses, comprise the most
important distinguishing criteria. Other relevant factors
include the reason for referral, age, sex, weight at time of
intake (for infants), number of hours of artificial respiration,
duration of hospitalization and reason for discharge. Using
case-based lump-sums, all general hospital services for a
defined case type are remunerated at the same rate for both
SHI and private health insurance members, regardless of
the actual costs and duration of hospitalization. The DRG
system has been binding for all hospitals, except for
psychiatry, psychosomatic and psychotherapy (here hospital
departmental rates apply) since 1st January 2004. A DRG
institute—the Institute for the Hospital Remuneration
System (Institut für das Entgeltsystem im Krankenhaus,
InEK)—was established, whose duties include performing
the calculations and adjustment of the case group system
required for the annual negotiation of remuneration rates [1,
2, 4] (Tables 5 and 6).
Nursing insurance in Germany
Nursing insurance encompasses and organizes the tasks of
the ambulatory and nursing treatment. The main task
(service guarantee contract) is ensuring insurees receive
sufficient, uniform nursing care that meets the recognized
standards of medical nursing care. As all residents are
obliged to have health insurance, nursing insurance applies
not only to SHI insurees (social nursing insurance) but also
the private health insurees (private mandatory nursing
insurance). Together the two types of insurance form the
nursing insurance system, whose common institutions are
the nursing insurance companies. Although integrated in
and administrated by the health insurance companies, the
funds of the nursing and health insurance companies are
managed in strict separation. Nursing insurers are required
to negotiate service provision contracts with the funding
bodies of nursing facilities. The contracts must specify the
type, content and extent of the general nursing services,
which the nursing facility is obliged to provide and for
which it is entitled to receive remuneration from the nursing
insurers (contracted nursing institutes are also entitled to
state investment funding). The nursing facility has to meet
certain requirements to enter into a service provision
contract. For instance, the nursing facilities (ambulatory,
partial inpatient, or full inpatient) must be managed by a
qualified nursing specialist, guarantee performance-oriented
and cost-efficient nursing care, have a proven in-house
quality management system and meet specified staffing
prerequisites. Additionally, every nursing facility has to
conclude a nursing contract with each nursing recipient.
Once the service provision contract has been concluded, the
insurers remunerate facilities directly. In return, the insuree
receives benefits-in-kind in the form of nursing and
domestic services from the nursing facilities or a nursing
care allowance (a combination of services and cash is also
possible). Regardless of whether a nursing allowance or
non-cash services are provided, persons requiring care are
entitled to the provision of nursing and technical aids (e.g.
wheelchairs and catheters), as well as additional funds to
improve the individual environment and to participation in
free nursing courses. If a nursing allowance is provided, the
person requiring nursing care is obliged to participate in a
nursing consultation every six (care classification I/II) or
3 months (care classification III). The consultation is carried
out in the person’s home, identifies possible improvements,
and allows the insurers to monitor and secure the quality of the
nursing care provided. Furthermore, the Medical Review
Board of the Statutory Health Insurance Funds (Medizinischer
Dienst der Krankenversicherung, MDK), an institution of
the health and nursing insurance companies, also conducts
external quality monitoring, whereby homes can be visited
by appointment, care facilities without appointment, docu-
ments can be viewed, and persons requiring care, family
members and staff can be questioned. If the terms of the
contract are (repeatedly) violated, the service provision
contract can be cancelled by the nursing insurer with
immediate effect. The results of inpatient quality monitoring
are also publicized.
Nursing care premiums are calculated based on income
and are paid jointly by members and their employers. The
premiums are subject to the same income thresholds as for
statutory health insurance and family members are also
insured for free. Nursing care insurance is not designed to
comprehensively cover all necessary nursing care needs,
but simply ensures basic nursing and home care. Although,
like the SHI system, the social nursing insurance system is
also managed by a self-administrated public corporation, it
cannot determine its own premiums, and is subject to a set
rate (currently 1.95%). Thus, the emphasis is on keeping
premiums stable and any increase in costs in one area
results in a reduction of services elsewhere. The nursing
insurance system employs a system of general revenue and
cost sharing, which is implemented by the German Federal
(Social) Insurance Office. Here, the nursing care insurers
Table 5 Number of hospitals and hospital beds [8]
1995 2000 2008
Hospitals 2,325 2,242 2,083
Hospital beds 609,123 559,651 503,360
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determine their monthly turnover, including operating costs
and reserve funds and transfer any excess funds in full to a
revenue sharing fund set up by the insurance office. On the
other hand, if expenditure is higher than the incoming
funds, the nursing insurance company is paid the difference
from the revenue sharing fund.
Another difference to the SHI system is that an
applicant’s need for nursing care is not decided by an
independent physician, but by the Medical Review Board
of the Statutory Health Insurance Funds. The person
requiring nursing care submits an application for services
to the nursing care insurer, which in turn instructs the
review board to assess the type and extent of nursing care
required. Assessment by the review board is a contractual
obligation for the nursing care insurers. It must conform to
the needs-criteria guidelines and be conducted in the
applicant’s domestic environment. An applicant must
consent to the assessment and has to meet certain criteria
to qualify for nursing care. For instance, one stipulation is
that a need for assistance has existed in significant or high
measure for the usual and regularly occurring tasks of
everyday life (physical care, nutrition, mobility, housework)
due to a physical, mental or emotional illness or disable-
ment for at least 6 months. If the review board determines
that the applicant indeed requires nursing, the expert
evaluator makes recommendations as to the level of nursing
required, as well as the type and extent of measures
necessary to reverse, lessen the need for nursing care or
prevent the need from becoming greater. The recommen-
dations include whether the care should be provided in the
home environment or in a care facility, which specific types
of assistance are necessary, whether the tasks should be
carried out by an assistant partially or in full, whether the
person requiring care needs to be supervised or guided.
Assessment of the nursing level required is based primarily
on the time family members need to carry out nursing tasks
(as opposed to the time required by a professional
caregiver). Care classification I is defined as a significant
need for care, including at least 90 min a day of support, of
which 45 min consists of basic care. Classification II covers
those in high need of care, who need assistance at least
180 min (120 min basic care) at least 3 times daily and
additionally require help with housework several times a
week. Classification III covers those in highest need of
nursing, who require at least 300 min of nursing (240 min
basic care) every day at any time, including at night, and
additionally require help with housework several times a
week. If the condition of a nursing recipient worsens, the
review board can assign a higher care classification in a
follow-up assessment. Fees for the necessary nursing
services vary according to the care classification and only
in extreme cases can the nursing insurer provide services
that exceed the specifications of care classification III, as
unlike statutory health insurance, nursing insurance is not
subject to the principle of meeting needs.
Government guidelines dictate that, if possible, the nursing
should be provided in the recipient’s domestic environment by
family members and neighbors. For this reason, one goal
pursued by the nursing insurance system is encouraging
relatives and neighbors to provide the nursing care. For
instance, the nursing insurance law provides for bonus
payments for the social security premiums of caregivers.
Caregivers also have the right to remuneration for full
inpatient care or care by another caregiver or institution for a
maximum of 4 weeks per calendar year in cases of illness or to
take holidays. In crisis situations, when the home care cannot
be ensured by another caregiver or nursing facility, temporary
partial or full inpatient care is covered by the nursing insurer,
also for up to 4 weeks a calendar year [1, 3] (Table 7).
Table 6 The 10 most frequent inpatient diagnoses in Germany in 2008 [6]
Women Men
1 Live births according to place of birth 240,513 Mental and behavioral disorders due to alcohol 245,971
2 Heart failure 186,090 Live births according to place of birth 241,649
3 Malignant neoplasm of the breast [mammary] 149,919 Angina pectoris 169,917
4 Cholelithiasis 137,761 Heart failure 164,620
5 Essential (primary) hypertension 133,470 Hernia inguinalis 150,612
6 Gonarthrosis [knee osteoarthritis] 131,602 Chronic ischemic heart disease 143,728
7 Stroke 113,600 Acute myocardial infarction 133,635
8 Femur fracture 112,691 Malignant neoplasm of lung and bronchus 129,637
9 Perineal tear during birth 109,843 Cerebral injury 126,348
10 Atrial flutter and fibrillation 105,008 Atrial flutter and fibrillation 113,833
Table 7 Number of hospitals and hospital bed [6]
2000 2007
Inpatient nursing care facility 8,859 11,029
Nursing beds 645,456 799,059
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Ambulatory nursing in Germany
Ambulatory nursing facilities include welfare centers with a
multitude of different, cooperating professions under one
roof (nursing staff, social workers, occupational therapists,
family therapists) and private nursing care services (usually
owned by individuals). A variety of different funding
bodies meet the expense of these services. For example,
the social nursing insurance company remunerates the
nursing services and pays the nursing allowance in cases
of long-term care, the statutory health insurance company
covers home nursing and domestic assistance, public
funding covers social welfare services and investment
funding at state level, while private households cover all
other costs. The remuneration is paid as lump sums for so-
called service packages, which include several frequently
required nursing services [1, 3].
Inpatient nursing
Inpatient nursing care can be full-time (24-h care), part-
time (only during the day or at night) or short-term
(temporary full inpatient nursing for up to 4 weeks per
calendar year). As domestic environments, aged homes are
not considered to be inpatient nursing facilities. Potential
inpatients are entitled to preliminary information in easily
understood language, which must explain the services,
the available additional services (which have to be re-
munerated separately on a user-pays basis), fees and the
results of quality monitoring. Contracts are generally
concluded for an indefinite period and any increase in fees
must be clearly justified. A nursing facility resident can
only be evicted in important, justifiable cases (in this case,
the facility is obliged to find the resident a comparable
facility and cover the moving costs). In contrast, a resident
can quit the contract at anytime and with immediate effect,
if, for instance, significant service deficits exist (here
too, the nursing facility must pay for the cost of relocation)
[1, 3].
Supply of medicine in Germany
Under German law, medicine is defined as materials and
preparations of materials intended to cure, alleviate,
prevent or diagnose diseases, ailments, physical injury
or other physical complaints when applied to or in the
human or animal body. Furthermore, materials used for
diagnosis on or in the human body, or which replace
bodily fluids (e.g. blood supplies), are also defined as
medicine. Generally the medicines are propriety medicinal
products; only in rare cases are medicines prepared on-site in
pharmacies (e.g. as tinctures). The German Drugs Act
(Arzneimittelgesetz, AMG) regulates the manufacture, approval
and dispensing of medicine, as well as government monitoring
of drug supply. In contrast, the drug price ordinance
(Arzneimittelpreisverordnung, AMPreisV) regulates the condi-
tions under which pharmaceutical wholesalers and pharmacists
can increase prices. As part of ensuring that medicine
supply to humans and animals proceeds according to
applicable rules and regulations, the state must provide
for safety in the handling and distribution of medicine, in
particular for the quality, effectiveness and harmlessness
of the medicine. The state meets this obligation by
issuing quality standards and monitoring drug manufac-
turing, distribution and dispensing. The main federal
institutions involved in this regulation and monitoring are
the Federal Institute for Medicines and Medicine Products
(Bundesinstitut für Arzneimittel und Medizinprodukte,
BfArM), which is responsible for approving proprietary
medicinal products, the Paul Ehrlich Institute, which is
responsible for approving vaccinations, sera and blood
products and the Institute for Quality and Efficiency in
Healthcare (IQWiG), which assesses the effectiveness,
quality and efficiency of pharmaceuticals. State authorization
and evidence of special expert knowledge is required to
manufacture pharmaceuticals in Germany. Industrial manu-
facturers include the Federal Association of Pharmaceutical
Industry (BPI), the Association of Researching Medicine
Manufacturers (VFA) and the Federal Professional Association
of Medicine Manufacturers (BAH).
All approved medicines, as well as all companies and
institutions that manufacture, assess, store, package or
distribute drugs are subject to state monitoring. Manufac-
turers can be obliged to include particular information a
medicine’s package information leaflet, or, in the case of
serious side effects, recall the medicine from the market.
After detailed assessment, a product is initially approved
for 5 years, after which the approval can be extended
indefinitely. When a medicine is newly approved, the
manufacturer has the right to set the retail price and the
drug is protected by patent for a total of 20 years. Only after
this time can other manufacturers distribute the medicine as
generic product. The manufacturer supplies the approved
proprietary medicinal products to pharmaceutical whole-
salers, who in turn supply the pharmacies (via a legally
regulated distribution channel). Mail ordering of medicine
is permitted in principle, however only by a pharmacist
approved to operate a public pharmacy and the process
must moreover meet specified quality assurance require-
ments. Excluding hospital pharmacies, the manufacture,
distribution and sale is undertaken by private companies
(pharmaceutical manufacturers, wholesalers, pharmacies).
The pharmacy law (Apothekengesetz, ApoG) and the
rules governing the operation of pharmacies (Apothekenbe-
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triebsordnung, ApBetrO) specify the prerequisites and
requirements for the operation of a pharmacy (e.g. apart
from government approval by the relevant state authority, a
pharmacist’s license is required, and specials requirements
regarding the building, equipment and staffing also exist).
Pharmacies are divided into public (i.e. open to the public)
stores and hospital pharmacies, which only supply inpa-
tients (and under certain conditions, outpatients). Like
physicians, pharmacists are obliged to join a state associ-
ation. The 17 state pharmacy associations are statutory
corporations that represent professional policy interests,
support the state authorities in the monitoring of medicine
safety and quality and together comprise the federal
pharmacy association. Furthermore, the profession has
organized itself into 17 lobby associations, which together
form the German Pharmacists’ Association (Deutscher
Apothekerverband), which represents the pharmacists’
economic interests at federal level. The Federal Association
of German Pharmacist Associations (ABDA) is the um-
brella organization of state-level statutory pharmacists’
associations and lobby associations, and represents the
professional interests of pharmacists in the public sphere
and in policy questions.
While manufacturers are in principle free to set their
prices as they wish, wholesalers and pharmacists must
adhere to surcharge limits and guarantee hospitals a legally
fixed price reduction of currently 2.30 euros per medicine.
Wholesalers and pharmacists must also comply with the
mark-up limits for proprietary medicinal products defined
in the drug price ordinance (AMPreisV). Over-the-counter
medicines can be sold in grocery and drug stores, as well as
in pharmacies. In contrast, prescription drugs may only be
sold in pharmacies. Yet another class of drugs can only be
sold in pharmacies, but do not require a doctor’s prescrip-
tion. Narcotics are subject to the narcotics law and may
only be distributed under special rules and documentation.
SHI insurees are entitled to the provision of medically
necessary drugs. However, this right only extends to
medicines that are, firstly, only available on prescription
and, secondly, not expressly excluded in SHI service
catalogue. Only in extremely serious diseases and under
strict conditions can non-prescription medicines be pre-
scribed for coverage by the statutory health insurance
company. The SHI system is not obliged to cover drugs
that relieve minor ailments (e.g. flu and cold medicine, mild
painkillers and lifestyle medicines such as appetite sup-
pressants, hair-growth aids, and sexual potency drugs). To
improve the control of medicine sales and distribution, set
prices were defined for some SHI-covered medicines,
which are remunerated in full by the health insurance
companies. If higher prices are demanded (e.g. by the
pharmacies), the insuree has to pay the difference directly.
Additionally, every SHI insuree aged 18 years or more
has to pay 10% of the retail price of every prescribed
medicine (minimum of 5 euros, maximum of 10 euros).
Peculiar to Germany is that physicians are prohibited from
dispensing medicine to patients, except for small amounts
of samples and medicine required directly during the
consultation.
The dispensing of medicine to private patients and SHI
insurees is essentially identical, except that private patients
are reimbursed for the expense of the medicine rather than
receiving the medicine directly. Although the medicine
sales and distribution system is also jointly self-governed,
the agreements between health insurance companies and
SHI-approved physicians, which are subject to the medicine
guidelines of the Federal Joint Committee, carry more
weight than the framework agreements between the
insurance companies and medicine manufacturers or phar-
macist associations. As in other aspects of the health
system, health insurance companies and the association of
SHI physicians have to negotiate the total expenditure on
medicine and remedies in advance for the coming year [1,
5, 10, 13] (Tables 8 and 9).
Table 9 Funding of the German healthcare system as compared
with international standards (in percent of gross domestic product)
[1, 14]
1995 2000 2005
Austria 9.8 10.0 10.2
Belgium 8.2 8.6 10.3
Denmark 8.1 8.3 9.1
Finland 7.5 6.6 7.5
France 9.9 9.6 11.1
Germany 10.1 10.3 10.7
Great Britain 7.0 7.3 8.3
Greece 7.5 9.3 10.1
Ireland 6.7 6.3 7.5
Italy 7.3 8.1 8.9
Luxembourg 5.6 5.8 7.9
Netherlands 8.3 8.0 9.2
Portugal 7.8 8.8 10.2
Spain 7.4 7.2 8.3
Sweden 8.1 8.4 9.1
Switzerland 9.7 10.4 11.6
USA 13.3 13.2 15.3
Table 8 Number of pharmacies [6]
2000 2009
Pharmacies 21,592 21,548
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